| Literature DB >> 17159989 |
Jiasheng Zhang1, Vanee Pho, Stephen J Bonasera, Jed Holtzman, Amy T Tang, Joanna Hellmuth, Siuwah Tang, Patricia H Janak, Laurence H Tecott, Eric J Huang.
Abstract
Transforming growth factor beta (TGFbeta) is a potent trophic factor for midbrain dopamine (DA) neurons, but its in vivo function and signaling mechanisms are not entirely understood. We show that the transcriptional cofactor homeodomain interacting protein kinase 2 (HIPK2) is required for the TGFbeta-mediated survival of mouse DA neurons. The targeted deletion of Hipk2 has no deleterious effect on the neurogenesis of DA neurons, but leads to a selective loss of these neurons that is due to increased apoptosis during programmed cell death. As a consequence, Hipk2(-/-) mutants show an array of psychomotor abnormalities. The function of HIPK2 depends on its interaction with receptor-regulated Smads to activate TGFbeta target genes. In support of this notion, DA neurons from Hipk2(-/-) mutants fail to survive in the presence of TGFbeta3 and Tgfbeta3(-/-) mutants show DA neuron abnormalities similar to those seen in Hipk2(-/-) mutants. These data underscore the importance of the TGFbeta-Smad-HIPK2 pathway in the survival of DA neurons and its potential as a therapeutic target for promoting DA neuron survival during neurodegeneration.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17159989 PMCID: PMC3578579 DOI: 10.1038/nn1816
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 24.884